HRT Financial’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

HRT Financial’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$519K	Sell	17,328 -27,840	-62%	-$790K	﹤0.01%	2634
2026 Q1	$1.35M	Buy	+45,168	New	+$1.5M	﹤0.01%	1868
2025 Q4	–	Sell	-8,697	Closed	-$301K	–	3483
2025 Q3	$301K	Buy	+8,697	New	+$278K	﹤0.01%	2169
2024 Q4	–	Sell	-16,241	Closed	-$467K	–	2694
2024 Q3	$467K	Buy	+16,241	New	+$442K	﹤0.01%	1617
2021 Q4	–	Sell	-39,608	Closed	-$2.08M	–	3508
2021 Q3	$2.08M	Buy	39,608 +32,436	+452%	+$1.93M	0.01%	707
2021 Q2	$494K	Sell	7,172 -4,322	-38%	-$330K	﹤0.01%	1794
2021 Q1	$886K	Buy	+11,494	New	+$1.06M	0.01%	1270
2020 Q4	–	Sell	-2,760	Closed	-$391K	–	2077
2020 Q3	$391K	Buy	+2,760	New	+$460K	0.01%	1001
2019 Q3	–	Sell	-8,697	Closed	-$1.12M	–	1465
2019 Q2	$1.12M	Buy	+8,697	New	+$1.03M	0.07%	250

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

HRT Financial's LKFT Position: Q2 2026 in Review

HRT Financial reduced its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 62% in Q2 2026, selling an estimated $790K and leaving 17,328 shares worth $519K. The position accounts for ﹤0.01% of the portfolio, ranked #2634.

HRT Financial first reported a position in LKFT in Q2 2019 and has held it in 9 quarters since. The position peaked at $2.08M in Q3 2021. 76 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

HRT Financial held 17,328 shares of Lakefront Biotherapeutics American Depositary Shares worth $519K as of Q2 2026.
HRT Financial sold 27,840 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $790K.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2634 holding.
HRT Financial first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2019 and has held it in 9 quarters since.
HRT Financial's Lakefront Biotherapeutics American Depositary Shares position peaked at $2.08M in Q3 2021.
76 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.